Breast Cancer Trial, Not Yet Recruiting NCT07190651 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Not Yet Recruiting

NCT07190651
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • A person must provide written consent to participate before joining the trial.
  • Participants must be 18 years of age or older.
  • A confirmed diagnosis of a specific type of breast cancer (hormone receptor-positive and HER2-negative) is required, based on laboratory testing, where the cancer cannot be treated with surgery or radiation aimed at a cure.
  • Participants must currently be receiving a combination of a CDK4/6 inhibitor and hormone therapy as the first treatment for their metastatic (spread) breast cancer, and must have been on this treatment for at least 2 months, in line with local guidelines.
  • There must be no signs of the cancer growing or spreading, based on the treating doctor's assessment of clinical or imaging findings.
  • Participants must have a general health and activity level that meets a certain standard, measured by a scale called the ECOG performance status, with a score of 2 or lower (confirm with trial site).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with a history of significant neurological or psychiatric conditions that would prevent them from fully understanding and agreeing to participate in the trial.
  • People who currently have another active invasive cancer, or who are currently receiving any other cancer-fighting treatment alongside the one being studied.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 October 2025
Est. completion
30 September 2026

Primary endpoints

Concordance between the results of the questionnaire and the clinical examination of the patients.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov